Last reviewed · How we verify
Placebo matching with Metformin XR — Competitive Intelligence Brief
marketed
Diabetes
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo matching with Metformin XR (Placebo matching with Metformin XR) — Bristol-Myers Squibb. This is a placebo formulation matched to Metformin XR for use as a control in clinical trials, containing no active pharmaceutical ingredient.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo matching with Metformin XR TARGET | Placebo matching with Metformin XR | Bristol-Myers Squibb | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo matching with Metformin XR CI watch — RSS
- Placebo matching with Metformin XR CI watch — Atom
- Placebo matching with Metformin XR CI watch — JSON
- Placebo matching with Metformin XR alone — RSS
Cite this brief
Drug Landscape (2026). Placebo matching with Metformin XR — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-matching-with-metformin-xr. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab